Oct 2026· ACS Nano· Vol 20 41, pp.
27920-27930
· 0 citations· 40 references
Medicine
TL;DR
This work engineer the human tetraspanin CD9 as a modular scaffold for displaying nanobodies on recombinant EV surfaces, using a high-throughput single-EV imaging platform to screen candidate constructs at the individual vesicle level and establishes single-EV imaging as a fast and quantitative screening tool for identifying productive surface-display constructs.
Abstract
Extracellular vesicles (EVs) are emerging nanoscale platforms for targeted drug delivery, yet rational design of their surface composition is limited by a lack of systematic, high-throughput approaches for identifying productive protein-display constructs. Here, we engineer the human tetraspanin CD9 as a modular scaffold for displaying nanobodies (VHHs) on recombinant EV surfaces, using a high-throughput single-EV imaging platform to screen candidate constructs at the individual vesicle level. Guided by conservation analysis and structural prediction, we mapped seven insertion sites across CD9's extracellular loops and termini and identified positions that support functional transgene display. Nonconserved regions within the short extracellular loop (SEL) yielded the highest counts of functional recombinant EVs - an empirical result that runs counter to the a priori expectation that the larger long extracellular loop (LEL) would be more permissive. We demonstrate the platform's modularity by interchangeably incorporating fluorescent proteins and VHHs against GFP, HER2, EGFR, and PD-L1 at optimized SEL positions, where the displayed VHHs bound their cognate antigens with high specificity (∼70-90% co-localization and minimal off-target binding). Co-transfection of host cells with dual constructs yielded EVs co-displaying two independent functional moieties on ∼80% of vesicles. This work establishes single-EV imaging as a fast and quantitative screening tool for identifying productive surface-display constructs and provides a generalizable workflow for producing multifunctional, transgene-displaying EVs with potential downstream bioanalytical, diagnostic, and therapeutic applications.
Recent progress in integrating aptamers into EV research is highlighted across three interconnected domains: the selection of aptamers against EV-associated surface markers; the development of aptamer-based methods for EV capture and isolation; and the use of aptamer-functionalized EVs for targeted drug delivery and im...
Xue-Fei Li, You-Yu Zhang, Dan-Ping Zhang et al.· Extracellular Vesicles and C...· 0 citations
Multiplexed protein profiling of single extracellular vesicles (EVs) is crucial for precise liquid biopsy but is severely limited by steric hindrance arising from bulky detection probes. This study systematically deconstructs the sources and consequences of this limitation using high-sensitivity nano-flow cytometry (nF...
Yun-Yun Hu, Hao-Nan Di, Lin-Jun Lin et al.· Small Methods· 0 citations
Extracellular vesicles (EVs) are mediators of intercellular communication and promising protein-delivery vehicles, but isolation of sufficiently pure, intact, engineered EVs remains challenging due to abundant cellular and serum-derived contaminants. Here, structure-guided engineering of the canonical EV tetraspanins,...
M. Pham, J. B. Krohn, Janis Meyer et al.· Small· 0 citations
Protein-based nanocages are emerging as promising platforms for next-generation medicine because of their programmable architecture, biocompatibility, and capacity for functional integration. In the field of immunotherapy, these properties offer a structural basis for overcoming key limitations of conventional antibody...
Wonkyung Ahn, Seong A. Kim, Yeram Lee et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.